Sutro Biopharma Inc.
STRO | NASDAQ
$16.30
-$0.05 (-0.31%)
Sep 22, 2026, 12:32 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.84M | 14.52M | 11.65M | 9.69M | 63.75M | 17.4M | 14.81M | 8.52M | 25.71M | 13.01M | 113.72M | 16.92M | 10.41M | 12.67M | 8.63M | 25.15M | 28.1M | 5.9M | 10.65M | 8.52M | 28.05M | 14.66M |
Cost of Revenue | n/a | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a | 1.79M | 1.76M | n/a | n/a | 41.59M | n/a | 43.14M | n/a | n/a | 29.99M | 29.93M | 26.6M | 25.31M | 22.56M |
Gross Profit | 9.84M | 13.25M | 11.65M | 9.69M | 63.75M | 17.4M | 14.81M | 8.52M | 23.92M | 11.25M | 113.72M | 16.92M | -31.18M | 12.67M | -34.5M | 25.15M | 28.1M | -24.09M | -19.27M | -18.09M | 2.74M | -7.9M |
Operating Income | -29.89M | -29.61M | -33.66M | -48.46M | -3.35M | -68.51M | -65.26M | -67.92M | -48.69M | -56.59M | 43.15M | -44.01M | -46.18M | -42.24M | -49.22M | -21.21M | -19.38M | -39.13M | -35.04M | -34.67M | -9.81M | -19.01M |
Interest Income | 1.72M | 1.64M | 1.53M | 2.01M | 2.52M | 3.19M | 3.86M | 27.04M | 4.91M | 4.1M | 4.56M | 4.55M | 2.84M | 2.56M | 2.13M | 1.01M | 197K | 116K | 96K | 109K | 175K | 197K |
Pretax Income | -38.53M | -38.5M | -46.84M | -56.86M | -11.52M | -75.97M | -70.09M | -48.79M | -48.01M | -58.21M | 46.87M | -47.45M | -38.37M | -49.66M | -34.59M | -19.49M | -23.51M | -39.11M | -38.13M | -30.9M | -6.15M | -30.36M |
Net Income | -38.53M | -38.48M | -46.76M | -56.86M | -11.5M | -75.97M | -72.44M | -48.79M | -48.02M | -58.21M | 31.07M | -49.28M | -38.52M | -50.05M | -34.59M | -19.49M | -26.01M | -39.11M | -38.13M | -30.9M | -6.15M | -30.36M |
Selling & General & Admin | 7.83M | 7.58M | 8.66M | 8.74M | 10.34M | 13.27M | 9.03M | 14.33M | 12.37M | 10.96M | 16.8M | 15.27M | 15M | 15.51M | 14.72M | 14.64M | 15.14M | 15.04M | 15.76M | 16.59M | 12.55M | 11.11M |
Research & Development | 31.7M | 36.55M | 36.64M | 39.85M | 38.33M | 51.6M | 71.04M | 62.11M | 62.02M | 56.88M | 53.77M | 45.67M | 41.59M | 39.4M | 43.14M | 31.71M | 32.33M | 29.99M | 29.93M | 26.6M | 25.31M | 22.56M |
Other Expenses | 201K | -1.28M | n/a | 9.56M | 18.42M | 21.04M | n/a | n/a | -1.79M | n/a | n/a | n/a | -41.59M | n/a | -43.14M | n/a | n/a | -29.99M | -29.93M | -26.6M | -25.31M | -22.56M |
Operating Expenses | 39.73M | 42.86M | 45.3M | 58.15M | 67.09M | 85.91M | 80.07M | 76.44M | 72.6M | 67.84M | 70.57M | 60.94M | 15M | 54.91M | 14.72M | 46.36M | 47.48M | 15.04M | 15.76M | 16.59M | 12.55M | 11.11M |
Interest Expense | 9.86M | 9.47M | 10.33M | 10.41M | 9.65M | 10.64M | 8.69M | 7.91M | 9.04M | 9.4M | 8.73M | 8.68M | 3.36M | 2.99M | n/a | 2.79M | 594K | 657K | 612K | 820K | 847K | 858K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.73M | 44.14M | 45.3M | 58.15M | 67.09M | 85.91M | 80.07M | 76.44M | 74.39M | 69.6M | 70.57M | 60.94M | 56.59M | 54.91M | 57.85M | 46.36M | 47.48M | 45.03M | 45.69M | 43.19M | 37.85M | 33.67M |
Income Tax Expense | 1K | -15K | -82K | n/a | -18K | n/a | 2.36M | n/a | 8K | n/a | 15.81M | 1.84M | 151K | 395K | n/a | n/a | 2.5M | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 16.57M | 13.08M | 8.58M | 8.49M | 8.46M | 8.31M | 8.25M | 8.2M | 8.12M | 6.15M | 6.1M | 6.06M | 6.03M | 5.87M | 5.68M | 5.23M | 4.7M | 4.65M | 4.6M | 4.61M | 4.61M | 4.59M |
Shares Outstanding (Diluted) | 16.57M | 13.08M | 8.58M | 8.49M | 8.46M | 8.31M | 8.25M | 8.2M | 8.12M | 6.15M | 6.1M | 6.06M | 6.03M | 5.87M | 5.68M | 5.23M | 4.7M | 4.65M | 4.62M | 4.62M | 4.61M | 4.59M |
EPS (Basic) | -2.33 | -2.94 | -5.45 | -6.70 | -1.40 | -9.10 | -8.80 | -5.90 | -5.90 | -9.50 | 5.10 | -8.10 | -6.40 | -8.50 | -6.50 | -3.40 | -5.50 | -8.40 | -8.30 | -6.70 | -1.30 | -6.60 |
EPS (Diluted) | -2.33 | -2.94 | -5.45 | -6.70 | -1.40 | -9.10 | -8.80 | -5.90 | -5.90 | -9.50 | 5.10 | -8.10 | -6.40 | -8.50 | -6.50 | -3.40 | -5.50 | -8.40 | -8.30 | -6.70 | -1.30 | -6.60 |
EBITDA | -27.41M | -27.75M | -34.89M | -44.55M | 1.07M | -45.57M | -59.53M | -39.08M | -38.93M | -49.27M | 57.34M | -37.03M | -33.29M | -45.05M | -33.07M | -15.26M | -21.52M | -37.13M | -36.2M | -28.96M | -4.19M | -17.72M |
EBIT | -28.67M | -29.03M | -36.52M | -46.45M | -826K | -47.47M | -61.4M | -40.88M | -40.72M | -51.03M | 55.6M | -38.77M | -35.02M | -46.67M | -34.59M | -16.7M | -22.92M | -38.45M | -37.51M | -30.08M | -5.31M | -19.01M |
Depreciation & Amortization | 1.26M | 1.28M | 1.62M | 1.9M | 1.9M | 1.9M | 1.87M | 1.8M | 1.79M | 1.76M | 1.73M | 1.74M | 1.73M | 1.62M | 1.53M | 1.44M | 1.4M | 1.33M | 1.32M | 1.12M | 1.12M | 1.29M |
Add to Watchlist
Select watchlists to add or remove STRO